-
Parkinson’s Study Finds New Compound that Can Inhibit Alpha-Synuclein
A newly identified small molecule compound, called SynuClean-D, can prevent the formation of toxic alpha-synuclein aggregates, an animal study shows. Click here to read more about SynuClean-D and its potential impact for people with Parkinson’s.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.